SWOG clinical trial number
SWOG-8592
Evaluation of Low -Dose Ara-C versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndrome,
Closed
Phase
Published
Abbreviated Title
Evaluation of Low -Dose Ara-C versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndrome,
Activated
07/01/1984
Closed
07/01/1988
Publication Information Expand/Collapse
1992
Evaluation of low dose cytarabine in the treatment of the myelodysplastic syndromes: A phase III intergroup study.
Phase III evaluation of low-dose cytosine arabinoside versus supportive care in the treatment of adults with myelodysplastic syndrome: An Intergroup study of the Eastern Cooperative Oncology Group and the Southwest Oncology Group - preliminary results.
1989
Pathogenetic implications of internuclear bridging in myelodysplastic syndrome. An Eastern Cooperative Oncology Group/Southwest Oncology Group Cooperative Study